Search Results

$9 million grant supports new study of utilizing semaglutide for non-alcoholic fatty liver disease.

Union Health Ministry releases updated NAFLD guidelines to improve patient care, emphasizing early detection, lifestyle changes, and holistic care strategies

Using the latest technologies—advanced 3D glass imaging of mice to characterize key scar-producing liver cells—researchers have uncovered novel candidate drug targets for NAFLD

State health department initiates early intervention program amid growing non-alcoholic fatty liver disease prevalence

While obesity and diabetes are well-known risk factors for fatty liver disease, the UT Southwestern researchers were able to identify a new cause of fatty liver disease absent obesity.

MAFLD is identified when more than 5% of the liver contains fat in individuals who do not consume alcohol excessively